Rajesh Devraj
@r_devraj
CEO, Rectify Pharma. Venture Partner, Atlas Venture. Experienced drug hunter, company builder, entrepreneur, recovering large pharma exec.
قد يعجبك
And to think ~25 years ago Pharma leadership teams (ours included) were debating if drugs will sell for ‘obesity’, as ostentatiously put, it is a lifestyle disease.
$LLY Q3 tirzepatide (Mounjaro/Zepbound) sales: $10.1 billion. $MRK Q3 Keytruda sales $8.1 billion. The passing of the torch...
That is so authentic! You keep fighting Stan the Man. We will keep rooting for you. @stanwawrinka
PASSION - A strong liking, desire, or devotion to an activity. When I started playing tennis at 8 years old, it was just a game. Then it became my passion. My dream was to one day became a professional tennis player. I know that as an athlete, people like to think they know…
Repost far and wide! Thanks for the narrative @simonmaechling
This “study” looks serious. It has an abstract, authors, even affiliations. But read it carefully - it’s pure satire. And it brilliantly exposes one of the biggest flaws in bad science: confusing correlation with causation. “Over 90% of autistic children consumed breast milk or…
This “study” looks serious. It has an abstract, authors, even affiliations. But read it carefully - it’s pure satire. And it brilliantly exposes one of the biggest flaws in bad science: confusing correlation with causation. “Over 90% of autistic children consumed breast milk or…
In April, biotech was the most hated sector of all time. I looked back today and found these two pieces that bucked the trend. Credit @david_wainer and @adamfeuerstein.
Here is my advice to pregnant women Talk to your doctor about the risks and benefits for you and your baby from any medicine Do not take advice from politicians
Federer spotted at Stanford👀👀 lachlan.ming IG
" Greatness on The Farm 🌲" Stanford Men’s Tennis IG
😌
King is holding court y’all.
A king of the court in the Royal Box 👑 Welcome back to Centre Court, @rogerfederer 👏 #Wimbledon
Yep. This👇🏼
USA is strong because of the people, not the government. We are a nation of individuals who either got thrown out or chose to come here. A nation founded by immigrants. Freedom of speech. Of religion. To not be oppressed by government. Celebrate our freedom.
#ICYMI: Our CEO, @r_devraj, joined Sam Kessel on the @NucleateHQ podcast to talk target validation, PFMs, and the mission driving Rectify’s work in #PSC and beyond. 🎧 Tune in: bit.ly/4dYMuqQ
🎙️Building Biotech: From the Bench to the Boardroom Raj Devraj (CEO @RectifyPharma, Venture Partner @AtlasVC) shares hard-won lessons on capital efficiency, target validation & startup leadership. A must-listen for biotech founders. 👇 signal.nucleate.xyz/building-biote…
At #EASLCongress 2025 we’re presenting data that demonstrates the potential for a B4/BSEP PFM to address the core pathology of multiple liver & biliary diseases, incl. #PrimarySclerosingCholangitis. Read more: bit.ly/4m8O2lP
We’re attending the 62nd @ERAkidney Congress June 4–7! We’ll present new transitional data from our cardio-renal-metabolic program addressing critical unmet needs in kidney health. More on our presentation: bit.ly/4kvrMRM #ERA25
Thanks for the opportunity @Xtalks to discuss our lead program for #PSC and our #PFM platform that allows us to discover and develop oral, small molecule drugs to rectify membrane protein dysfunction.
Thanks for the opportunity @LongwoodLeaders to converse with a distinguished panel of execs who are balancing and derisking novel science, building novel platforms and bringing differentiated products to serve patients. @LongwoodFund @RectifyPharma
Insightful conversation on #drugdiscovery sciences with biotech CEOs Dee Datta Switch Therapeutics, Brent Vaughan, JJ Kang Appia Bio, Dominique Verhelle NextRNA Therapeutics, @r_devraj @RectifyPharma #longwoodhealthcareleaders #JPM25
Investors in Padlock Therapeutics sue Bristol Myers Squibb $BMY over ‘milestone’ payments The dark side of so-called biobucks deals, featuring @michael_gilman statnews.com/2024/12/12/pad…
I could not agree more with @JackScannell13
Furthermore, the productivity loss from small decrements in test validity (e.g., by adapting the test to reduce cycle time or to increase throughput) can swamp large gains in brute-force efficiency. Quality beats quantity. 6/8
Furthermore, the productivity loss from small decrements in test validity (e.g., by adapting the test to reduce cycle time or to increase throughput) can swamp large gains in brute-force efficiency. Quality beats quantity. 6/8
United States الاتجاهات
- 1. Good Sunday 55.5K posts
- 2. Dodgers 812K posts
- 3. Nigeria 846K posts
- 4. #sundayvibes 4,294 posts
- 5. World Series 436K posts
- 6. Talus 20.3K posts
- 7. Scott Adams 1,892 posts
- 8. Blessed Sunday 15.5K posts
- 9. Toronto 101K posts
- 10. Yankees 17.2K posts
- 11. Yamamoto 254K posts
- 12. Daylight Savings Time 6,760 posts
- 13. All Souls Day 4,865 posts
- 14. jungkook 390K posts
- 15. Standard Time 9,252 posts
- 16. Carlos Manzo 359K posts
- 17. Oakley 2,229 posts
- 18. Will Smith 56.5K posts
- 19. Harrison Ford 12.1K posts
- 20. Miguel Rojas 49.2K posts
قد يعجبك
-
Jeb Keiper
@JebKeiper -
Rosana Kapeller
@KapellerRosana -
Nello Mainolfi
@NelloMainolfi -
Alex Harding
@AlexHarding7 -
Jo Viney (she/her)
@76viney -
Art Krieg
@ArtKrieg -
Michael Gladstone
@MikeNGladstone -
David Schenkein
@schenkein -
Carol Suh
@carolysuh -
Ron Renaud
@biotech1969 -
George Vlasuk
@GVlasuk -
Vipin Suri
@VipinSuri4 -
Rick Lundberg
@RickLundberg
Something went wrong.
Something went wrong.